Related Experiment Video
Updated: Aug 17, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Non-alcoholic fatty liver disease (NAFLD) in children
1Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. eve.roberts@sickkids.ca
Insights
Childhood non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent. While simple fatty liver may be benign, non-alcoholic steatohepatitis (NASH) can cause serious liver issues, emphasizing the need for early obesity intervention in children.
Area of Science:
- Pediatric Hepatology
- Metabolic Disorders
- Public Health
Background:
- Childhood non-alcoholic fatty liver disease (NAFLD) is a significant and likely highly prevalent pediatric liver condition.
- The full spectrum of NAFLD, from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH), is observed in children.
- The long-term prognosis of simple hepatic steatosis in children remains uncertain, whereas NASH can lead to severe consequences like cirrhosis.
Purpose of the Study:
- To review the current understanding of childhood NAFLD, including its presentation, associated metabolic abnormalities, and management strategies.
- To highlight the link between childhood obesity and the rising incidence of pediatric NAFLD and NASH.
- To emphasize the need for early diagnosis and intervention for overweight children to prevent severe liver disease.
Main Methods:
- Review of existing literature on childhood NAFLD and NASH.
- Analysis of clinical presentation, diagnostic findings (imaging, labs), and risk factors in pediatric populations.
- Evaluation of current treatment approaches, focusing on lifestyle modifications.
Main Results:
- Childhood NAFLD presents with vague symptoms or incidental findings on imaging, often with moderate elevations in alanine aminotransferase (ALT) and hypertriglyceridemia.
- NASH can be more severe in certain ethnic groups and in children with metabolic disorders like lipodystrophy.
- Weight loss through diet and exercise is the primary treatment, with low glycemic index diets being a potential strategy.
Conclusions:
- Childhood obesity is a major driver of NAFLD, posing risks for severe chronic liver disease.
- Early identification and management of overweight children are crucial for preventing progression to NASH and cirrhosis.
- Effective management requires individual lifestyle changes and broader societal initiatives to combat the childhood obesity epidemic.
Abstract:
Childhood NAFLD has become an important childhood liver disease, and it is probably highly prevalent. The full of spectrum of NAFLD has been identified in children. It is not currently known whether or not simple hepatic steatosis in children is benign or whether it evolves to NASH over time. In contrast, childhood NASH certainly can have serious consequences. Cirrhosis is apparently rare in children with NAFLD, but it definitely occurs. Childhood NAFLD may occur in very young children, and there is no female predominance in the pediatric age bracket. Children present with vague abdominal pain, if they have any symptoms at all, but frequently hepatic steatosis is found incidentally on abdominal imaging. Laboratory studies show that serum aminotransferase abnormalities are rather moderate, with serum alanine aminotransferase (ALT) more elevated than serum aspartate aminotransferase (AST). Hypertriglyceridemia is the typical blood lipid abnormality, although hypercholesterolemia may occur. NASH may be more severe in children from certain ethnic groups, including Hispanics and Asians, or in association with certain metabolic disorders characterized by abnormalities in insulin receptor structure or signaling, such as lipodystrophy syndromes. Weight loss through dietary redesign and a regimen of regular exercise remains the mainstay for treatment for childhood NAFLD. A dietary strategy to minimize postprandial hyperinsulinemia and overall fat intake, such as a low glycemic index diet, may be the best dietary strategy. The real efficacy of drug treatments in children requires further investigation. The overriding message is that childhood obesity poses important health problems, including but not limited to potentially severe chronic liver disease. Early diagnosis of children who are only overweight is a worthy goal so that strategies to limit obesity can be instituted as early as possible. Identification of genetic risks is important, but management will invariably require changes in environmental factors. In addition to individual treatment, a multifaceted, societal initiative is required for solving the childhood obesity epidemic.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
